Urinary DNA methylation‐based risk stratification model to triage patients for repeat transurethral resection of bladder tumours
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Wei Ouyang, Ran Xu, Hanyu Yao, Shusuan Jiang, Qiang Lu, Cai Lv, Pei Li, Genming Xu, Jianye Liu, Long Wang |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2024
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Quality of transurethral resection of bladder tumour documentation: implications for non‐muscle‐invasive bladder cancer risk stratification and management
par: Abram Botros, et autres
Publié: (2024)
par: Abram Botros, et autres
Publié: (2024)
Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
par: Di Chen, et autres
Publié: (2024)
par: Di Chen, et autres
Publié: (2024)
Plasma cell‐free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma
par: Jacob E. Till, et autres
Publié: (2026)
par: Jacob E. Till, et autres
Publié: (2026)
Concurrent DNA hypomethylation and epigenomic reprogramming driven by androgen receptor binding in bladder cancer oncogenesis
par: Yu Xiao, et autres
Publié: (2024)
par: Yu Xiao, et autres
Publié: (2024)
Comprehensive genomic analysis of molecular residual disease based on circulating tumour DNA in postoperative patients with colorectal cancer
par: Qingqi Hong, et autres
Publié: (2024)
par: Qingqi Hong, et autres
Publié: (2024)
Machine learning‐based multi‐omics models for diagnostic classification and risk stratification in diabetic kidney disease
par: Xian Shao, et autres
Publié: (2025)
par: Xian Shao, et autres
Publié: (2025)
Role of DNA methylation in cancer development and its clinical applications
par: Swarup Sonar, et autres
Publié: (2024)
par: Swarup Sonar, et autres
Publié: (2024)
Targeting senescence‐associated secretory phenotypes to remodel the tumour microenvironment and modulate tumour outcomes
par: Jiaqiang Xiong, et autres
Publié: (2024)
par: Jiaqiang Xiong, et autres
Publié: (2024)
Alterations of the immune microenvironment with age predicts patient prognosis of gastrointestinal tract tumours
par: Fangzhen Li, et autres
Publié: (2026)
par: Fangzhen Li, et autres
Publié: (2026)
DNA methylation variability in pediatric aplastic anaemia contributes to T‐cell differentiation
par: Junchen Lai, et autres
Publié: (2026)
par: Junchen Lai, et autres
Publié: (2026)
The carbon footprint of the perioperative transurethral resection of bladder tumour pathway
par: Joseph B. John, et autres
Publié: (2024)
par: Joseph B. John, et autres
Publié: (2024)
Spatial transcriptomics deciphers the immunosuppressive microenvironment in colorectal cancer with tumour thrombus
par: Heming Ge, et autres
Publié: (2024)
par: Heming Ge, et autres
Publié: (2024)
Early postoperative plasma circulating tumour DNA for molecular residue disease detection and recurrence risk evaluation in surgical non‐small cell lung cancer
par: Jie Tang, et autres
Publié: (2024)
par: Jie Tang, et autres
Publié: (2024)
Infiltrating characteristics and prognostic value of tertiary lymphoid structures in resected gastric neuroendocrine neoplasm patients
par: Daming Cai, et autres
Publié: (2024)
par: Daming Cai, et autres
Publié: (2024)
Epigenetic dynamics in gastric cancer precancerous lesions: From molecular mechanisms to precision risk stratification
par: Kewei Ma, et autres
Publié: (2025)
par: Kewei Ma, et autres
Publié: (2025)
High KRT17 expression in tumour budding indicates immunologically ‘hot’ tumour budding and predicts good survival in patients with colorectal cancer
par: Wenfeng Liang, et autres
Publié: (2024)
par: Wenfeng Liang, et autres
Publié: (2024)
Single‐cell landscape of the tumour immune microenvironment in human gynaecologic malignancies
par: Simin Yin, et autres
Publié: (2025)
par: Simin Yin, et autres
Publié: (2025)
Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis
par: Carmen González‐Olmedo, et autres
Publié: (2024)
par: Carmen González‐Olmedo, et autres
Publié: (2024)
Distinctive cell‐free DNA methylation characterizes presymptomatic genetic frontotemporal dementia
par: Lucia A. A. Giannini, et autres
Publié: (2024)
par: Lucia A. A. Giannini, et autres
Publié: (2024)
Longitudinal circulating tumour DNA dynamics predict failure patterns and efficacy of consolidation immunotherapy after chemoradiotherapy in locally advanced non‐small‐cell lung cancer
par: Yu Wang, et autres
Publié: (2024)
par: Yu Wang, et autres
Publié: (2024)
High‐throughput single‐cell DNA methylation and chromatin accessibility co‐profiling with SpliCOOL‐seq
par: Qingmei Shen, et autres
Publié: (2026)
par: Qingmei Shen, et autres
Publié: (2026)
Comprehensive review and updated analysis of DNA methylation in hepatocellular carcinoma: From basic research to clinical application
par: Lin Su, et autres
Publié: (2024)
par: Lin Su, et autres
Publié: (2024)
Spatiotemporal characteristics of neurophysiological changes in patients with four‐repeat tauopathies
par: Niyatee Samudra, et autres
Publié: (2024)
par: Niyatee Samudra, et autres
Publié: (2024)
Phase II clinical trial of nirogacestat in patients with relapsed ovarian granulosa cell tumours
par: Rachel N. Grisham, et autres
Publié: (2026)
par: Rachel N. Grisham, et autres
Publié: (2026)
DNA methylation profiles reveals STAB1‐mediated endothelial cell and immune cell interactions in Moyamoya disease
par: Shihao He, et autres
Publié: (2025)
par: Shihao He, et autres
Publié: (2025)
Pathologic nodal metastasis assessment using tumour‐derived molecular features in patients with lung adenocarcinoma
par: Shijie Wang, et autres
Publié: (2024)
par: Shijie Wang, et autres
Publié: (2024)
Improving detection of colorectal cancer: A Bayesian approach to serial circulating tumour DNA testing following curative‐intent treatment.
par: Susanne K. Pedersen, et autres
Publié: (2026)
par: Susanne K. Pedersen, et autres
Publié: (2026)
Outcomes of intermediate or high‐risk CMML patients treated with hypomethylating agents combined with venetoclax: A single center experience
par: Chao Li, et autres
Publié: (2024)
par: Chao Li, et autres
Publié: (2024)
Comment on: ‘Residents surgical training using metrics for transurethral resection of bladder tumours’
par: Pietro Diana, et autres
Publié: (2025)
par: Pietro Diana, et autres
Publié: (2025)
Research progress on fusion genes in tumours
par: Yinyi Chang, et autres
Publié: (2024)
par: Yinyi Chang, et autres
Publié: (2024)
Bisulfite‐free PCDHGB7 methylation in urine enables early noninvasive detection of urothelial carcinoma
par: Zhicong Yang, et autres
Publié: (2025)
par: Zhicong Yang, et autres
Publié: (2025)
Titin gene mutations enhance radiotherapy efficacy via modulation of tumour immune microenvironment in rectum adenocarcinoma
par: Hengchang Liu, et autres
Publié: (2025)
par: Hengchang Liu, et autres
Publié: (2025)
Therapeutic potential and impact of nanoengineered patient‐derived mesenchymal stem cells in a murine resection and recurrence model of human glioblastoma
par: Rawan Al‐Kharboosh, et autres
Publié: (2024)
par: Rawan Al‐Kharboosh, et autres
Publié: (2024)
Targeting CLEC4E in immunosuppressive tumour‐associated macrophages via BET inhibition
par: Mengting Liao, et autres
Publié: (2025)
par: Mengting Liao, et autres
Publié: (2025)
A multi‐centre, prospective trial of a methylation‐based liquid biopsy for early detection of liver cancer in high‐risk populations
par: Ruohan Zhang, et autres
Publié: (2026)
par: Ruohan Zhang, et autres
Publié: (2026)
Oncolytic viruses: Revolutionising the fight against tumours
par: Zeda Zhao, et autres
Publié: (2025)
par: Zeda Zhao, et autres
Publié: (2025)
Three‐dimensional chromatin landscapes in somatotroph tumour
par: Jing Guo, et autres
Publié: (2024)
par: Jing Guo, et autres
Publié: (2024)
A multi‐omic biomarker signature in pre‐treatment rectal tumours stratifies patients with different pathological responses to neoadjuvant treatment
par: Laura E. Kane, et autres
Publié: (2025)
par: Laura E. Kane, et autres
Publié: (2025)
Transitional CXCL14+ cancer‐associated fibroblasts enhance tumour metastasis and confer resistance to EGFR‐TKIs, revealing therapeutic vulnerability to filgotinib in lung adenocarcinoma
par: Weijiao Xu, et autres
Publié: (2025)
par: Weijiao Xu, et autres
Publié: (2025)
Lactylation in cancer: Mechanisms in tumour biology and therapeutic potentials
par: Yipeng He, et autres
Publié: (2024)
par: Yipeng He, et autres
Publié: (2024)
Documents similaires
-
Quality of transurethral resection of bladder tumour documentation: implications for non‐muscle‐invasive bladder cancer risk stratification and management
par: Abram Botros, et autres
Publié: (2024) -
Unveiling the functional roles of patient‐derived tumour organoids in assessing the tumour microenvironment and immunotherapy
par: Di Chen, et autres
Publié: (2024) -
Plasma cell‐free DNA markers predict occult metastases in patients with resectable pancreatic ductal adenocarcinoma
par: Jacob E. Till, et autres
Publié: (2026) -
Concurrent DNA hypomethylation and epigenomic reprogramming driven by androgen receptor binding in bladder cancer oncogenesis
par: Yu Xiao, et autres
Publié: (2024) -
Comprehensive genomic analysis of molecular residual disease based on circulating tumour DNA in postoperative patients with colorectal cancer
par: Qingqi Hong, et autres
Publié: (2024)